The prescribed dose in milligrams is transferable between products
GLP-1 receptor agonists are drugs that mimic the function of glucagon-like peptide-1 (GLP-1), a hormone produced in the gut that has multiple roles in regulating blood sugar levels and appetite
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, prior serious hypersensitivity to semaglutide, active or severe pancreatitis history, severe gastroparesis, and during pregnancy or breastfeeding
Enhances glucose-dependent insulin secretion while suppressing glucagon in fasting and postprandial states through GLP-1R signaling
Understanding the documented interaction, optimal timing strategies, and monitoring requirements ensures safe, effective concurrent use under medical supervision